NKT cells as modulators of AIDS vaccine efficacy
NKT 细胞作为艾滋病疫苗功效的调节剂
基本信息
- 批准号:8660612
- 负责人:
- 金额:$ 9.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-06-19 至 2015-01-05
- 项目状态:已结题
- 来源:
- 关键词:AIDS VaccinesAcquired Immunodeficiency SyndromeAdenovirus VectorAdjuvantAfrica South of the SaharaAntigensApplications GrantsAttenuatedB-LymphocytesBloodCellsCellular ImmunityCollaborationsConsensusCytomegalovirusDataDendritic CellsDeveloping CountriesDevelopmentDoseEpidemicFrequenciesFutureGlycolipidsGrantHIVHIV AntibodiesHIV vaccineHerpesviridaeHumanHumoral ImmunitiesImmuneImmune responseImmune systemImmunityInfectionInfection ControlInfusion proceduresLaboratoriesLettersLifeMacacaMacaca mulattaMediatingModelingMonitorMucosal ImmunityMucous MembraneNatural Killer CellsPlayPropertyRecombinantsRegimenResearchRoleSIVSIV VaccinesShapesSterilityT cell responseT-Cell ActivationT-LymphocyteT-Lymphocyte SubsetsTechniquesTestingTherapeuticTissuesVaccinatedVaccinationVaccine AdjuvantVaccinesViraladaptive immunityantibody-dependent cell cytotoxicitybasehumanized monoclonal antibodiesimmunogenicityimprovedin vivoinnovationkiller T cellkillingsmucosal siteneutralizing antibodynonhuman primatenovelpathogenperipheral bloodpreventprotective efficacyresearch studyvaccine developmentvaccine efficacyvector vaccine
项目摘要
DESCRIPTION (provided by applicant): Thirty years into the AIDS epidemic, there are an estimated 34 million HIV-infected people worldwide and almost 70% reside in sub-Saharan Africa. Although intensive research towards developing an AIDS vaccine is continuing, there are as yet no effective HIV vaccines on the horizon. For a HIV vaccine to be successful, it is widely accepted that it should be able to induce mucosal immunity, elicit an effective cytolytic and polyfunctional HIV-specific T cell response along with anti-HIV antibodies that have broadly directed neutralization activity and antibody dependent cellular cytotoxicity (ADCC) activity. The innate immune system is an important modulator of adaptive immunity and can shape the magnitude, quality, and durability of pathogen-specific immune responses at systemic and mucosal sites. Natural killer T (NKT) cells are unique T cells of the innate immune system with potent immunoregulatory properties that can impact T and B cell immunity. In this grant application we propose to use the SIV infection macaque model to investigate the hypothesis that NKT activation will improve vaccine immunogenicity and improve vaccine-mediated protection against acquisition and control of SIV infection. Conversely, the absence of NKT cells may reduce the efficacy of a protective live attenuated SIV (LASIV) vaccine. Our specific aims are: #1. Determine the optimal dosing regimen for in vivo administration of the NKT-depleting and NKT-activating mAbs and characterize their effect in blood and tissues of cynomolgus macaques. #2. Investigate the hypothesis that the adjuvant effect of NKT activation will enhance the protective efficacy of a heterologous prime-boost recombinant Ad26/Ad5-SIV vaccine regimen. #3. Investigate the hypothesis that vaccination in the setting of NKT depletion will abrogate the protective efficacy of a highly protective LASIV vaccine.
描述(由申请人提供):艾滋病流行三十年来,全球估计有3400万艾滋病毒感染者,近70%居住在撒哈拉以南非洲。 虽然正在继续进行开发艾滋病疫苗的密集研究,但目前还没有有效的艾滋病毒疫苗。对于成功的HIV疫苗,广泛接受的是它应该能够诱导粘膜免疫,引发有效的细胞溶解和多功能HIV特异性T细胞应答,沿着具有广泛定向中和活性和抗体依赖性细胞毒性(ADCC)活性的抗HIV抗体。先天免疫系统是适应性免疫的重要调节剂,并且可以在全身和粘膜部位形成病原体特异性免疫应答的幅度、质量和持久性。 自然杀伤T(NKT)细胞是先天免疫系统中独特的T细胞,具有可影响T和B细胞免疫的有效免疫调节特性。在这项资助申请中,我们建议使用SIV感染猕猴模型来研究NKT激活将改善疫苗免疫原性并改善疫苗介导的对SIV感染的获得和控制的保护的假设。相反,NKT细胞的缺乏可能会降低保护性减毒SIV活疫苗(LASIV)的效力。我们的目标是:#1。确定NKT消耗和NKT激活mAb体内给药的最佳给药方案,并表征其在食蟹猴血液和组织中的作用。#2.研究NKT激活的佐剂效应将增强异源初免-加强免疫重组Ad 26/Ad 5-SIV疫苗方案的保护效力的假设。#3.研究在NKT耗竭的情况下接种疫苗将废除高度保护性LASIV疫苗的保护效力的假设。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amitinder Kaur其他文献
Amitinder Kaur的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amitinder Kaur', 18)}}的其他基金
Role of maternal-fetal interface NK cells in pregnancy maintenance and congenital CMV transmission
母胎界面 NK 细胞在妊娠维持和先天性 CMV 传播中的作用
- 批准号:
10392103 - 财政年份:2022
- 资助金额:
$ 9.55万 - 项目类别:
Role of maternal-fetal interface NK cells in pregnancy maintenance and congenital CMV transmission
母胎界面 NK 细胞在妊娠维持和先天性 CMV 传播中的作用
- 批准号:
10586146 - 财政年份:2022
- 资助金额:
$ 9.55万 - 项目类别:
CMV infection impact on placental immunometabolism and fetal immunity
CMV感染对胎盘免疫代谢及胎儿免疫力的影响
- 批准号:
10536197 - 财政年份:2022
- 资助金额:
$ 9.55万 - 项目类别:
NKT cells as modulators of AIDS vaccine efficacy
NKT 细胞作为艾滋病疫苗功效的调节剂
- 批准号:
9022675 - 财政年份:2012
- 资助金额:
$ 9.55万 - 项目类别:
NKT cells as modulators of AIDS vaccine efficacy
NKT 细胞作为艾滋病疫苗功效的调节剂
- 批准号:
8846538 - 财政年份:2012
- 资助金额:
$ 9.55万 - 项目类别:
NKT cells as modulators of AIDS vaccine efficacy
NKT 细胞作为艾滋病疫苗功效的调节剂
- 批准号:
8492032 - 财政年份:2012
- 资助金额:
$ 9.55万 - 项目类别:
NKT cells as modulators of AIDS vaccine efficacy
NKT 细胞作为艾滋病疫苗功效的调节剂
- 批准号:
8409973 - 财政年份:2012
- 资助金额:
$ 9.55万 - 项目类别:
ROLE OF NATURAL KILLER T (NKT) LYMPHOCYTES IN SOOTY MANGABEYS
自然杀伤 T (NKT) 淋巴细胞在乌白眉猴中的作用
- 批准号:
8357526 - 财政年份:2011
- 资助金额:
$ 9.55万 - 项目类别:
CHARACTERIZATION OF MHC CLASS I ALLELES IN SOOTY MANGABEYS
乌白眉猴 MHC I 类等位基因的特征
- 批准号:
8357924 - 财政年份:2011
- 资助金额:
$ 9.55万 - 项目类别:
CELLULAR IMMUNE RESPONSES IN SIV-INFECTED SOOTY MANGABEYS
感染 SIV 的乌白眉猴的细胞免疫反应
- 批准号:
8357908 - 财政年份:2011
- 资助金额:
$ 9.55万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 9.55万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 9.55万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 9.55万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 9.55万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 9.55万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 9.55万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 9.55万 - 项目类别: